Skip to content

Endurant® II ETLW1613C93E (UDI 00613994991539)Recalls & reported problems

Medtronic, Inc. · STENT GRAFT ETLW1613C93E ENDUR II LIMB · Class 3 · Implant

All models of Endurant II (114)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
5
Deaths reported
0
Injuries reported
2
Recalls naming it
0

Summary

The FDA's MAUDE database contains 5 adverse event reports that list this exact device (DI 00613994991539), received between May 9, 2017 and Sep 30, 2024 — classified as 2 injuries, 3 malfunctions.

The most frequently reported specific device problem is “Leak/Splash” (5 reports).

6 other recalls cover devices cleared under the same FDA submission (P100021); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Reports received per month

Nov 2023: 0 reportsDec 2023: 0 reportsJan 2024: 0 reportsFeb 2024: 0 reportsMar 2024: 0 reportsApr 2024: 0 reportsMay 2024: 0 reportsJun 2024: 0 reportsJul 2024: 0 reportsAug 2024: 1 reportsSep 2024: 1 reportsOct 2024: 0 reportsNov 2024: 0 reportsDec 2024: 0 reportsJan 2025: 0 reportsFeb 2025: 0 reportsMar 2025: 0 reportsApr 2025: 0 reportsMay 2025: 0 reportsJun 2025: 0 reportsJul 2025: 0 reportsAug 2025: 0 reportsSep 2025: 0 reportsOct 2025: 0 reportsNov 2025: 0 reportsDec 2025: 0 reportsJan 2026: 0 reportsFeb 2026: 0 reportsMar 2026: 0 reportsApr 2026: 0 reportsMay 2026: 0 reportsJun 2026: 0 reportsJul 2026: 0 reportsAug 2026: 0 reportsSep 2026: 0 reportsOct 2026: 0 reports2024202520261
Last 36 months. The most recent month may be incomplete.

Most reported problems

Device problems

  • Leak/Splash5
  • Migration or Expulsion of Device2

Patient problems

  • Injury3
  • No Consequences Or Impact To Patient2
  • Abdominal Pain1
  • Insufficient Information1

Recent adverse event reports

The 5 most recent of 5 reports, in the reporter's own words as published by the FDA.

  • InjurySep 30, 2024Leak/Splash; Leak/Splash

    AN ENDURANT II AUI STENT GRAFT SYSTEM WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF A 60MM AAA. AN ENDURANT CUFF ETCF2828C49E WAS IMPLANTED 10 YEARS AND FIVE MONTHS LATER DUE TO A TYPE IA ENDOLEAK WHICH WAS IDENTIFIED ON AN UNKNOWN DATE. IT WAS REPORTED THAT THE PATIENT PRESENTED EMERGENTLY THE FOLLOWING MONTH AND A IB ENDOLEAK WAS OBSERVED IN THE LEFT ILIAC LIMB ETLW1613C93E . INTERVENTION WAS PERFORMED ON THE SAME DAY AND A LIMB EXTENSION WAS IMPLANTED. THIS RESOLVED THE IB ENDOLEAK. PER THE PHYSICIAN THE CAUSE OF THE IB ENDOEAK WAS ANATOMY RELATED DUE TO ILIAC DISEASE PROGRESSION. NO CAUSE OF THE IA ENDOLEAK WAS PROVIDED. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT IS FINE.

    Patient problems: Insufficient Information

    MAUDE report 20331549 ↗
  • MalfunctionAug 12, 2024Leak/Splash; Migration or Expulsion of Device; Leak/Splash; Migration or Expulsion of Device

    AN ENDURANT IIS STENT GRAFT SYSTEM WAS IMPLANTED DURING THE ENDOVASCULAR TREATMENT OF AN AAA. IT WAS REPORTED APPROXIMATLEY 9 YEARS POST THE INDEX PROCEDURE, THAT THE PATIENT PRESENTED TO THE ER WITH ABDOMINAL PAIN AND A CT SHOWED A IA ENDOLEAK AND BILATERAL IB ENDOLEAKS. BOTH LIMBS HAVE MIGRATED INTO THE ANEURYSM SAC. NO FUTURE REPAIR IS PLANNED AS THE FAMILY CHOSE PALLIATIVE CARE. PER THE PHYSICIAN THE CAUSE OF THE EVENT WAS DUE TO AORTIC DEGENERATION AND REMODELING. NO ADDITIONAL CLINICAL SEQUALAE WERE PROVIDED AND THE PATIENT WILL BE MONITORED.

    Patient problems: Abdominal Pain

    MAUDE report 19960271 ↗
  • MalfunctionJan 3, 2018Leak/Splash; Leak/Splash

    AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 50MM DIAMETER ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT A CT EXAM PERFORMED APPROXIMATELY 2 YEARS POST IMPLANT, THE PATIENTS RIGHT ILIAC ARTERY DIAMETER MEASURED BETWEEN 12.7-13MM.THE CT EXAM ALSO REVEALED A TYPE IB ENDOLEAK ON THE RIGHT SIDE. AS PER THE PHYSICIAN, THE CAUSE OF THE EVENT CANNOT BE DETERMINED. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT WILL BE MONITORED BY THE PHYSICIAN.

    Patient problems: Injury; No Consequences Or Impact To Patient

    MAUDE report 7159517 ↗
  • MalfunctionNov 29, 2017Leak/Splash; Leak/Splash

    AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 67MM DIAMETER ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT APPROXIMATELY 3 MONTHS POST INDEX PROCEDURE, ON FOLLOW UP CT, THE PHYSICIAN WAS CONCERNED ABOUT THE POSSIBLE PRESENCE OF A TYPE IA ENDOLEAK. A TYPE IB ENDOLEAK WAS SUSPECTED WITHIN (B)(4). AS PER THE PHYSICIAN, THE CAUSE OF THE EVENT IS DUE TO ANATOMY AS THE INFRARENAL AORTA AND RIGHT COMMON ILIAC APPEAR TO HAVE DILATED SINCE THE INITIAL IMPLANT OF THE STENT GRAFTS. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT WILL BE MONITORED BY THE PHYSICIAN

    Patient problems: Injury; No Consequences Or Impact To Patient

    MAUDE report 7066179 ↗
  • InjuryMay 9, 2017Leak/Splash; Migration or Expulsion of Device; Leak/Splash; Migration or Expulsion of Device

    AN ENDURANT II STENT GRAFT SYSTEM WAS IMPLANTED IN A PATIENT FOR THE ENDOVASCULAR TREATMENT OF A 5 CM IN DIAMETER ABDOMINAL AORTIC ANEURYSM. IT WAS REPORTED THAT THE PATIENT HAD FALLEN AND HIT THEIR SIDE AND PRESENTED EMERGENTLY TO THE HOSPITAL. CURRENTLY, THE ABDOMINAL AORTIC ANEURYSM IS 7 CM IN DIAMETER. A CT REVEALED BILATERAL DISTAL TYPE I ENDOLEAKS AND THE STENT GRAFTS APPEARED TO HAVE MIGRATED PROXIMALLY. THE ANGIOGRAM CONFIRMED BILATERAL DISTAL TYPE I ENDOLEAKS. THE PHYSICIAN DECIDED TO IMPLANT ENDURANT ILIAC LIMBS BILATERALLY EXTENDING THE ILIAC LIMBS INTO THE COMMON ILIAC ARTERIES. THE BILATERAL DISTAL TYPE I ENDOLEAKS WERE RESOLVED. THE PHYSICIAN STATED THAT THE CAUSE OF THE BILATERAL DISTAL TYPE I ENDOLEAKS AND LIMB MIGRATION WERE RELATED TO THE PATIENT¿S ANATOMY OF CONTINUED DISEASE PROGRESSION OF THE COMMON ILIAC ARTERIES. NO ADDITIONAL CLINICAL SEQUELAE WERE REPORTED AND THE PATIENT IS FINE.

    Patient problems: Injury

    MAUDE report 6555942 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under P100021. One submission often covers many models, so check the product and lot details in each record.

  • Z-0292-2022 · Oct 15, 2021 · Open, Classified
    Endurant IIs Stent Graft System REF/Description: ESBF2814C103EE STENT GRAFT ESBF2814C103EE ENDUR IIS BIF ESBF2814C103EE STENT GRAFT ESBF2814C103EE ENDUR IIS BIF ESBF2814C103EE STEN
  • Z-0290-2022 · Oct 15, 2021 · Open, Classified
    Endurant Stent Graft System REF/Description: ENTF2525C70EE STENT GRAFT ENTF2525C70EE ENDURANT TUBE
  • Z-0291-2022 · Oct 15, 2021 · Open, Classified
    Endurant II Stent Graft System REF/Description: ETBF2513C145EE STENT GRAFT ETBF2513C145EE ENDUR II BIF ETBF2820C166EE STENT GRAFT ETBF2820C166EE ENDUR II BIF ETBF2820C166EE STENT G
  • Z-2135-2021 · Jun 7, 2021 · Open, Classified
    Endurant II/Endurant IIs Stent Graft System: Medtronic Endurant II Stent Graft System REF ETUF3214C102EE, ETCF3636C49EE, ETBF3216C166EE, and ETUF3614C102E. Used to treat infra
  • Z-2136-2021 · Jun 7, 2021 · Open, Classified
    Medtronic Endurant IIs Stent Graft System Medtronic Endurant IIs Stent Graft System REF ESBF3614C103EE and ESBF3214C103E. Used to treat infrarenal abdominal aortic or aortoili
  • Z-1543-2017 · Feb 27, 2017 · Terminated
    Endurant / Endurant II 23mm and 25mm Bifurcated Stent Graft Systems Model Numbers: ETBF2516C145E ETBF2516C166E ETBF2316C145E ETBF2313C145E ETBF2513C166E ETBF2313C166E ETBF2316C166

Other SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices

All SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page